Theurapeutic approach combining PD-1/PD-L1 blockade and the inhibition of "new" immune checkpoints for the treatment of triple-negative breast cancer

Ancion, Marie

Poster (Scientific congresses and symposiums)

Ancion, Marie

2021 • European Association for Cancer Research Congress 2021

Permalink
https://hdl.handle.net/2268/263745

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

EACR21v-0238-PosterMarieAncion.pdf

Publisher postprint (2.59 MB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Immunotherapy; Triple-negative breast cancer

Research Center/Unit :

Laboratoire de Pathologie Expérimentale, GIGA-Cancer

Disciplines :

Oncology

Author, co-author :

Ancion, Marie ; Université de Liège - ULiège > GIGA Cancer - Experimental Pathology

Language :

English

Title :

Theurapeutic approach combining PD-1/PD-L1 blockade and the inhibition of "new" immune checkpoints for the treatment of triple-negative breast cancer

Publication date :

09 June 2021

Number of pages :

e-Poster

Event name :

European Association for Cancer Research Congress 2021

Event organizer :

EACR

Event date :

Du 9 juin au 12 juin 2021

Audience :

International

Name of the research project :

Therapeutic approach combining PD-1/PD-L1 blockade and the inhibition of “new” immune checkpoints for the treatment of triple-negative breast cancer

Funders :

F.R.S.-FNRS - Fonds de la Recherche Scientifique

Available on ORBi :

since 23 September 2021

Statistics

Number of views

55 (11 by ULiège)

Number of downloads

2 (2 by ULiège)

More statistics